Abbott Laboratories (ABT) Financials
Abbott Laboratories (ABT) Historical Financial Statements and Key Metrics for 1985 - 2026
Full Abbott Laboratories financials for 1985 - 2026 are available in the
US Historical Financials dataset
All financial data is sourced direct from SEC 10-Q and 10-K filings, restatements are included.
Abbott Laboratories Income Statements
(in $ 000,000's)
| Quarter End | Revenue | Gross Profit | Operating Income | Net Income | EBITDA | EPS |
| 2026-Jun-30 | 12,593 | 7,304 (58.0 %) | 1,782 (14.2 %) | 928 (7.4 %) | 1,782 | 0.53 |
| 2026-Mar-31 | 11,164 | 6,283 (56.3 %) | 1,842 (16.5 %) | 1,077 (9.6 %) | 2,247 | 0.62 |
| 2025-Dec-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Sep-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Jun-30 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2025-Mar-31 | 0 | 0 (0.0 %) | 0 (0.0 %) | 0 (0.0 %) | 0 | 0.00 |
| 2024-Dec-31 | 10,974 | 6,032 (55.0 %) | 1,911 (17.4 %) | 9,229 (84.1 %) | 2,989 | 5.27 |
Full historical income statements for 1985 - 2026 is included in the
US Historical Financials dataset.
Abbott Laboratories Balance Sheets
(in $ 000,000's)
| Quarter End | Total Assets | Total Liabilities | Total Debt | Total Equity | Cash & Equivalents |
| 2026-Jun-30 | 109,215 | 57,453 | 32,608 | 51,110 | 5,603 |
| 2026-Mar-31 | 110,429 | 57,728 | 34,047 | 52,061 | 7,295 |
| 2025-Dec-31 | 86,713 | 33,942 | 15,067 | 52,130 | 8,939 |
| 2025-Sep-30 | 84,181 | 32,917 | 12,941 | 50,954 | 7,733 |
| 2025-Jun-30 | 83,999 | 33,170 | 13,437 | 50,565 | 7,282 |
| 2025-Mar-31 | 81,448 | 32,384 | 13,242 | 48,811 | 6,844 |
| 2024-Dec-31 | 81,414 | 33,513 | 15,021 | 47,664 | 7,967 |
Full historical balance sheet data for 1985 - 2026 is included in the
US Historical Financials dataset.
Abbott Laboratories Cash Flow Statements
(in $ 000,000's)
| Quarter End | Operating Cash Flow | Investing | Financing | Free Cash Flow |
| 2026-Jun-30 | 2,488 | -673 | -3,518 | 2,887 |
| 2026-Mar-31 | 1,315 | -20,324 | 17,313 | 916 |
| 2025-Dec-31 | 3,315 | -913 | -1,397 | 2,626 |
| 2025-Sep-30 | 2,787 | -457 | -1,760 | 2,291 |
| 2025-Jun-30 | 2,047 | -582 | -1,097 | 1,545 |
| 2025-Mar-31 | 1,417 | -470 | -2,055 | 933 |
| 2024-Dec-31 | 2,868 | -866 | -1,861 | 2,148 |
Full historical cash flow data for 1985 - 2026 is included in the
US Historical Financials dataset.
Abbott Laboratories Key Valuation and Operating Metrics
| Quarter End | Market Capitalization ($ 000,000's) |
Enterprise Value ($ 000,000's) |
Price/Earnings ($ 000,000's) |
Price/Sales ($ 000,000's) |
Price/Book ($ 000,000's) |
| 2026-Jun-30 | 158,164 | 185,668 | 12.56 | 42.80 | 3.09 |
| 2026-Mar-31 | 179,360 | 206,604 | 16.07 | 41.40 | 3.45 |
| 2025-Dec-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Sep-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Jun-30 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2025-Mar-31 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 2024-Dec-31 | 195,872 | 203,277 | 17.85 | 5.31 | 4.11 |
Full historical valuation and operating metrics for 1985 - 2026 are included in the
US Historical Financials dataset.